C-aryl glucoside SGLT2 inhibitors and method | Patent Number 06515117

US 06515117 B2
Application Number10151436
Publication NumberUS 20020137903 A1
Pendency8 months, 20 days
Filled DateMay 20, 2002
Priority DateOct 12, 1999
Publication DateSep 26, 2002
Expiration DateOct 12, 2019
Inventor/ApplicantsBruce Ellsworth
Philip M. Sher
William N. Washburn
Philip M. Sher
Wei Meng
Bruce Ellsworth
Gang Wu
Gang Wu
William N. Washburn
Wei Meng
ExaminesKHARE, DEVESH
Art Unit1623
Technology Center1600
Assignments
Astrazeneca
Current
Bristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.